Michael Pulsipher

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Novartis
    Date added: 
    07/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Gentibio
    Date added: 
    07/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Bluebird
    Date added: 
    07/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Vertex
    Date added: 
    07/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Medexus
    Date added: 
    07/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Equillium
    Date added: 
    07/20/2022
Return to 2022 Cellular Therapy Conference – Translating recent evidence on cellular therapy to real world management of malignancies